Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 07 June, 2011 and appeared in  MedicationType 2 DiabetesType 1 DiabetesGLP-1 Series Issue 5GLP-1 Agonist

The Incretin Effect

For the complete article, The Incretin Effect, and information on other aspects of GLP-1 treatment, please visit Novo Nordisk's diabetesinamerica at www.novomedlink.com/diabetes/diabetes-in-america.

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 07 June, 2011 and appeared in  MedicationType 2 DiabetesType 1 DiabetesGLP-1 Series Issue 5GLP-1 Agonist

Past five issues: Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 | Diabetes Clinical Mastery Series Issue 83 | Issue 624 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Generics are usually just as safe and effective as the corresponding name-brand product.

Navigate Diabetes In Control
Search Articles On Diabetes In Control